FURIN and cancer: The recognition of furin as a virulence factor for disparate microbial pathogens ranging from Bacillus anthracis to SARS-CoV-2, and as a player in diseases ranging from atherosclerosis to cancer spurred the development of furin inhibitors as a novel broad-based therapeutic strategy.